Ireland
--:--IST
Latest
Budget 2027: €29.1bn for Health, Rare Disease Medicines Pilot Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Budget 2027: €29.1bn for Health, Rare Disease Medicines Pilot Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bari
Clinical trial register · Italy

Clinical Trials in Bari, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca31 Merck Sharp & Dohme LLC17 Hoffmann-La Roche16 University of Bari14 Fondazione Italiana Linfomi - ETS13
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Bari

442 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Boehringer Ingelheim
Phase 3
270
Bari, Catania, Padova, Pavia, Pisa, Torino
2026-11-09
Not yet open
Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders
NCT07748221Stigma of Mental Illness, Cancer, Psychiatric Comorbidity
Istituto Oncologico Veneto IRCCS
Observational
1,000
Aviano, Bari, Padova
2026-11-01
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Chieti, Bari, Castellana Grotte (BA), Catanzaro, Cosenza, Naples, Salerno, Ferrara
2026-10-26
Not yet open
Fondazione Italiana Linfomi - ETS
Observational
1,000
Candiolo, Castelfranco Veneto, Alessandria, Aviano, Bari, Bergamo, Bologna, Brescia
2026-10
Not yet open
Fondazione EMN Italy Onlus
Observational
92
Bari, Bologna, Brescia, Castelfranco Veneto, Como, Milan, Novara, Pavia
2026-10
Recruiting
Bristol-Myers Squibb
Phase 2
160
Misterbianco, Bari, Bergamo, Milan, Ravenna, Rozzano (MI)
2026-09-10
Not yet open
Laser Assisted Open Flap Debridement
NCT07807215Periodontal Disease, Periodontal Bone Loss
University of Bari Aldo Moro
Not applicable
20
Bari
2026-09-10
Recruiting
Incyte Corporation
Phase 3
426
Bari, Bergamo, Bologna, Catania, Florence, Genova, Meldola, Milan
2026-09-08
Not yet open
Gruppo Oncologico del Nord-Ovest
Phase 3
244
San Giovanni Rotondo, Tricase, Rozzano, Orbassano, Aviano, Bari, Bologna, Crema
2026-09-01
Recruiting
AstraZeneca
Phase 3
2,800
Bari, Bologna, Cosenza, Cremona, Genoa, Milan, Modena, Naples
2026-09-01
Not yet open
Augmented Reality Dentistry
NCT07814794Edentulism, Malocclusion; Displaced Teeth, TEETH EXTRACTION
University of Bari Aldo Moro
Not applicable
10
Bari
2026-09-01
Not yet open
BV-CHP Real-life and Biological Evidences in Patients With sALCL
NCT07467317Anaplastic Large Cell Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
100
Avellino, Aviano, Bari, Bergamo, Bologna, Candiolo, Legnano, Milan
2026-09
Not yet open
Neurocognitive Assessment in Long-Term Survivors of Lymphoma
NCT07652476Classic Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal B Cell Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
100
Ancona, Aviano, Bari, Legnano, Milan, Palermo
2026-09
Not yet open
Heart Care Foundation
Phase 3
600
Acquaviva delle Fonti, Altamura, Arezzo, Avellino, Bari, Casale Monferrato, Caserta, Catania
2026-09
Not yet open
Azienda USL Reggio Emilia - IRCCS
Observational
210
Bari, Bologna, Ferrara, Meldola, Milan, Modena, Naples, Reggio Emilia
2026-08-30
Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
DrugPALI-2108
Palisade Bio
Phase 2
204
Bari, Bologna, Matera, Negrar, Rome, Rozzano, San Giovanni Rotondo, Turin
2026-08-28
Recruiting
Kardigan, Inc.
Phase 3
332
Bari, Florence, Milan, Padova, Pavia, Roma, Rozzano, Trieste
2026-08-26
Recruiting
AstraZeneca
Phase 3
7,000
Alessandria, Bari, Bologna, Catania, Chieri, Cinisello Balsamo, Cosenza, Eboli
2026-08-21
Not yet open
GlaxoSmithKline
Phase 3
1,860
Bari, Foggia, Rome
2026-08-11
Recruiting
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study
NCT07746895C3 Glomerulopathy (C3G), Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
DrugPegcetacoplan
Swedish Orphan Biovitrum
Phase 4
150
Bari, Bologna, Foggia, Messina, Milan, Roma, Udine
2026-08-05
Recruiting
Boehringer Ingelheim
Phase 3
448
Ancona, Bari, Florence, Milan, Modena, Naples, Roma
2026-07-27
Recruiting
AstraZeneca
Phase 3
915
Bari, Florence, Padova, Roma, Rozzano, Tricase
2026-07-16
Recruiting
Boehringer Ingelheim
Phase 3
390
Bari, Florence, Milan, Naples, Palermo, Roma, Verona
2026-07-10
Recruiting
Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation
NCT07692490Liver Transplantation (LT), Ischemia-Reperfusion Injury, Early Allograft Dysfunction
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Not applicable
170
Ancona, Bari, Bergamo, Bologna, Genova, Modena, Padova, Palermo
2026-07-07
Recruiting
AstraZeneca
Phase 3
1,200
Bari, Bologna, Chieti, Milan, Modena, Naples, Roma
2026-07-06
Recruiting
Chiesi Italia
Observational
75
Arezzo, Bari, Bologna, Caserta, Monza, Naples, Palermo
2026-06-15
Not yet open
Evaluation of the Impact of Virtual Park on Training Motivation in Adult Patients
NCT07616050Post-stroke, Parkinson Disease, Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment (MCI)
Marta Mondellini
Not applicable
70
Bari, Telese Terme, Costa Masnaga, Milan, Montescano, Pavia, Pisa
2026-06
Not yet open
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
144
Bari, Bologna, Meldola, Foggia, Florence, Genova, Province of Macerata, Milan
2026-06
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bari, Bologna, Bolzano, Milan, Novara, Palermo, Pescara, Rimini
2026-05-31
Active, closed
Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms
NCT07825207Myelodysplastic Neoplasm, Myelodysplastic Syndrome
DrugEltrombopag
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Observational
100
Alessandria, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Mantua
2026-05-01
Not yet open
Stratification and Treatment in Early Psychosis Study - PROMOTE
NCT07434973Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis, Clinical High Risk for Developing Psychosis
DrugCannabidiol
University of Oxford
Phase 3
586
Bari, Naples, Pavia, Roma
2026-05-01
Not yet open
Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies
NCT07503366Type 1 Diabetes (T1D), Autoantibodies, Hyperglycemia, Impaired Glucose Tolerance (Prediabetes)
Società Italiana di Endocrinologia e Diabetologia Pediatrica
Observational
300
Ancona, Bari, Bolzano, Caserta, Catanzaro, Crotone, Florence, L’Aquila
2026-05
Not yet open
Fondazione Italiana Linfomi - ETS
Not applicable
170
Ancona, Avellino, Aviano, Bari, Brescia, Cagliari, Florence, Milan
2026-05
Recruiting
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
NCT07585890End-stage Liver Disease (ESLD), Acute Liver Failure, Liver Cirrhosis, Liver Transplantation
University Medical Center Groningen
Observational
10,000
Bari, Bergamo, Pisa, Torino
2026-04-21
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
150
Bari, Milan, Pavia
2026-04-16
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Observational
100
Bari, Bergamo, Bologna, Misterbianco, Monza, Milan, Modena, Padova
2026-04-14
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Meldola, Rozzano, Catselfranco Veneto, Florence, Bari, Bologna, Milan, Perugia
2026-04-09
Not yet open
Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?
NCT07295522Heart Failure, Acute Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF)
DrugGDMT
IRCCS Policlinico S. Donato
Phase 4
368
San Donato Milanese, Ancona, Bari, Cecina, Ferrara, Florence, Milan, Pisa
2026-04-08
Recruiting
Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia
NCT07451977Chronic Respiratory Failure, Hypoxemia, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease
Istituti Clinici Scientifici Maugeri SpA
Not applicable
114
Lumezzane, Veruno, Montescano, Bari, Pavia, Taranto
2026-04-02
Recruiting
Artificial Intelligence-Based Assessment of Endosseous Lesions
NCT07505485Maxillary Cyst, Mandibular Cyst
University of Bari Aldo Moro
Not applicable
10
Bari
2026-04-01
Recruiting
Boehringer Ingelheim
Phase 2
132
Ancona, Bari, Bologna, Messina, Milan, Pavia, San Giovanni Rotondo (FG), Verona
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Bergamo, Bari, Catanzaro, Bologna, Rome, San Donato Milanese (MI), Palermo, Pisa
2026-03-16
Recruiting
Incyte Corporation
Phase 3
700
Ancona, Aviano, Bari, Brescia, Candiolo, Catania, Milan, Naples
2026-03-05
Recruiting
argenx
Observational
100
Acquaviva delle Fonti, Ancona, Bari, Bergamo, Bologna, Catanzaro, Florence, Genova
2026-02-25
Recruiting
Boehringer Ingelheim
Phase 3
286
Bari, Bologna, Milan, Palermo, Pavia, Varese
2026-02-16
Recruiting
Kardigan, Inc.
Phase 2/3
332
Bari, Florence, Milan, Padova, Pavia, Roma, Rozzano, Trieste
2026-02-13
Recruiting
Sexual Well-being of Women Undergoing Mastectomy and Reconstruction
NCT07234461Mastectomy and Breast Reconstruction, Sexual Wellness
European Institute of Oncology
Not applicable
200
Bari, Bologna, Cesena, Forlì, Milan, Olbia, Padova, Palermo
2026-01-21
Recruiting
Boehringer Ingelheim
Phase 3
400
Bari, Milan, Misterbianco (CT), Naples, Orbassano (TO), Roma, Rozzano (MI), Verona
2026-01-16
Recruiting
University Hospital, Grenoble
Observational
1,600
Bari, Catanzaro, Rovigo, Sanremo, Torino, Trento, Trieste, Venice
2026-01-15
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Observational
419
Bari, Milan, Pavia, Torino, Veruno
2026-01-08
Recruiting
Autogenous Tooth Transplantation With Instrumentally Simulated Open Apex and Platelet-Rich Fibrin
NCT07393997Tooth Loss, Tooth Diseases, Reimplant; Complications
University of Bari Aldo Moro
Not applicable
5
Bari
2026-01-01
Recruiting
University of Bari
Observational
600
Bari
2026-01-01
Recruiting
AstraZeneca
Observational
218
Monserrato, Cona, San Giovanni Rotondo, Rozzano, Ancona, Bari, Brescia, Florence
2025-12-31
Recruiting
AstraZeneca
Observational
335
Salerno, Padova, Teramo, Treviso, Varese, Bari, Bergamo, Bologna
2025-12-20
Recruiting
Novartis Pharmaceuticals
Observational
250
Ancona, Bari, Brescia, Cona, Florence, Genova, Lecce, Messina
2025-12-17
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bari, Milan, Naples, Padova, Pisa, Roma, Rome
2025-12-12
Recruiting
European Myeloma Network B.V.
Phase 2
150
Ascoli Piceno, Bari, Bergamo, Bologna, Bolzano, Como, Milan, Novara
2025-12-12
Recruiting
Janssen Research & Development, LLC
Observational
200
Bari, Brescia, Iesi, Milan, Naples, Palermo, Pavia, Perugia
2025-12-04
Recruiting
GlaxoSmithKline
Phase 3
450
Meldola, Rozzano MI, Bari, Bologna, Candiolo, Genova, Milan, Padova
2025-12-03
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
1,260
Bari, Bologna, Catania, Ferrara, Milan, Novara, Palermo, Parma
2025-12-03
Recruiting
Janssen Research & Development, LLC
Observational
380
Avellino, Aviano, Bari, Bergamo, Brescia, Candiolo, Catania, Catanzaro
2025-12-03
Recruiting
Meyer Children's Hospital IRCCS
Observational
150
Bari, Milan, Naples, Roma, Torino, Florence
2025-12-02
Active, closed
University of Bari
Observational
100
Bari
2025-12-01
Active, closed
BAR-TAX - Tranexamic Acid in Bariatric Surgery.
NCT07401394Bariatric Surgery, Bariatric Patients, Bariatric Surgery Complications, Bleeding
DrugTranexamic Acid
Santa Maria Hospital - GVM Care & Research
Not applicable
1,000
Bari
2025-12-01
Recruiting
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Not applicable
24
Bari
2025-12-01
By invitation
ESWT vs Orthosis in Trigger Finger
NCT06737601Trigger Finger
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Not applicable
40
Bari
2025-11-15
Recruiting
Boehringer Ingelheim
Phase 3
670
Aviano (PN), Bari, Brescia, Florence, Meldola (FC), Orbassano (TO), Padova, Parma
2025-11-07
Recruiting
High-Energy Laser in the Conservative Treatment of Rhizarthrosis
NCT07566507Thumb Osteoarthritis, Hand Injuries, Laser, Exercise
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Not applicable
42
Bari
2025-11-01
Recruiting
Ciceri Fabio
Not applicable
62
Milan, Bari, Parma
2025-10-31
Recruiting
Safety and Performance Evaluation of CPB Venous and Arterial Cannulas
NCT07354841Cardiac Surgery, Heart Surgery, Cardiopulmonary Bypass, Coronary Surgery
Eurosets S.r.l.
Not applicable
80
Bari
2025-10-21
Recruiting
Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.
NCT07407465Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Rectal Cancer, Adenocarcinoma
DrugsTrastuzumab deruxtecan·Capecitabine·Bevacizumab
Gruppo Oncologico del Nord-Ovest
Phase 2
42
Bari, Florence, Milan, Ravenna, Rozzano, Tricase, Modena, Roma
2025-10-20
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Alessandria, Bari, Bologna, Brescia, Catania, Florence, Milan, Naples
2025-10-17
Recruiting
University of Campania Luigi Vanvitelli
Phase 3
480
Ancona, Avellino, Aviano, Bari, Brescia, Castellana Grotte, Catania, Catanzaro
2025-10-01
Recruiting
A Multi-domain Intervention for Healthy Aging
NCT06767410Healthy Volunteer Study
University of Bari
Not applicable
100
Adelfia, Bari
2025-10-01
Recruiting
Shock Waves in Knee Arthritis
NCT06833372Arthritis of Knee
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Not applicable
72
Bari
2025-10-01
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Bari, Genoa, Rome, Pisa, Castelfranco Veneto, Milan, Naples, Parma
2025-09-30
Not yet open
LUpus Eritematoso Sistemico NETwork and Registry
NCT07175610Systemic Lupus Erythematous (SLE)
Società Italiana di Allergologia, Asma e Immunologia Clinica
Observational
1,500
Ancona, Bari, Battipaglia, Cagliari, Florence, Mantua, Milan, Naples
2025-09-30
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Bari, Genova, Naples, Pavia
2025-09-30
Recruiting
Daiichi Sankyo
Phase 3
710
Bari, Bologna, Florence, Lecco, Milan, Torino
2025-09-30
Recruiting
VisionCare, Inc.
Not applicable
44
Bari, Bergamo, Ferrara, Florence, Roma
2025-09-23
Not yet open
piero portincasa
Not applicable
200
Bari
2025-09-15
Recruiting
Emotional Allodynia Questionnaire (AEQ) in Fibromyalgia (PEARL)
NCT07677631Fibromyalgia, Chronic Pain, Nociplastic Pain
University of Bari
Observational
425
Bari, Bologna, Cagliari, Naples, Verona
2025-09-10
Recruiting
AbbVie
Observational
2,795
Cona, Rome, Bari
2025-09-02
Recruiting
Ocus Innovation Ireland Limited
Phase 3
234
Bari, Milan, Padua
2025-09-01
Not yet open
University of Bari
Not applicable
124
Bari
2025-09-01
Active, closed
Amgen
Phase 3
350
Bari, Bergamo, Meldola (FC), Milan, Roma, Verona
2025-08-18
Recruiting
Novo Nordisk A/S
Phase 4
586
Bari, Catanzaro, Naples, Rome, Milan, Messina, Palermo, Fermo
2025-08-15
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Observational
50
Bari, Meldola, Ferrara, Genova, Lido di Camaiore, Lucca, Monza, Milan
2025-08-12
Recruiting
AstraZeneca
Phase 3
700
Arezzo, Bari, Bergamo, Chieti, Genoa, Milan, Naples, Palermo
2025-08-06
Recruiting
Intergruppo Melanoma Italiano
Observational
270
Bari, Genova, Milan, Modena, Naples, Padova, Perugia, Roma
2025-08-04
Recruiting
AstraZeneca
Phase 3
800
Alessandria, Aviano, Bari, Bologna, Catania, Florence, Haifa, Milan
2025-08-01
Recruiting
CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) Syndrome
NCT07468461Camptodactyly, Arthropathy, Coxa Vara, Pericarditis
Meyer Children's Hospital IRCCS
Observational
15
Bari, Florence, Genova, Milan, Padova, Roma, Udine
2025-08-01
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Ancona, Bari, Meldola, Milan, Monza, Pisa, Ravenna, Roma
2025-07-17
Active, closed
REal-life ON PARKinson's - ITaly (REONPARK-IT)
NCT07403799Parkinson Disease
Bial - Portela C S.A.
Observational
200
Bari, Brescia, Cagliari, Catanzaro, Chieti, Genova, Messina, Milan
2025-07-08
Not yet open
Intestinal Microbiota After PPI Treatment
NCT07036627Proton Pump Inhibitors, Human Gastrointestinal Tract, Gastroesophageal Reflux Disease
University of Bari
Observational
100
Bari
2025-07-06
Active, closed
AstraZeneca
Observational
315
Cittadella (PD), Montebelluna (TV), Aosta, Avellino, Bari, Bergamo, Brescia, Cagliari
2025-06-25
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Bari, Bergamo, Brescia, Cortona AR, Foggia, Forlì, Milan, Naples
2025-06-25
Recruiting
European Institute of Oncology
Observational
1,000
Ancona, Aviano, Bagno a Ripoli, Bari, Bergamo, Brescia, Brindisi, Busto Arsizio
2025-06-25
Recruiting
BeOne Medicines
Phase 3
630
Bari, Cagliari, Catania, Ferrara, Milan, Modena, Pagani
2025-06-11
Recruiting
BioNTech SE
Phase 3
480
Bari, Bologna, Catania, Meldola, Milan, Naples, Roma, Torino
2025-06-10
Recruiting
Calico Life Sciences LLC
Phase 2
240
Bari, Modena, Rome
2025-06-09
Not yet open
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
100
Bari, Bologna, Brescia, Cagliari, Ferrara, Florence, Genova, Messina
2025-06-01
By invitation
University of Bari Aldo Moro
Not applicable
80
Bari
2025-06-01
Not yet open
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
600
Orbassano, Bari, Bologna, Cagliari, Cuneo, Ferrara, Florence, Genova
2025-06-01
Recruiting
High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases - Fit4MedRob-Acute MND Project
NCT06822231Critical Illness Myopathy, Guillain Barré Syndrome, Critical Illness Polyneuromyopathy (CIPNM)
Istituti Clinici Scientifici Maugeri SpA
Not applicable
124
Bari, Genova, Milan, Modena, Montescano, Pavia, Roma, Telese Terme
2025-05-28
Active, closed
Sanofi
Phase 3
1,092
Rome, Bari, Foggia, Lecce, Milan, Parma
2025-05-22
Recruiting
Fondazione Don Carlo Gnocchi ETS
Not applicable
160
Acerenza, Bari, Genova, Messina, Milan, Montescano, Pavia, Rome
2025-05-20
Recruiting
Biogen
Phase 3
454
Bari, Fontevivo, Modena, Piacenza, Trieste, Genoa, Brescia, Ranica
2025-05-08
Recruiting
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
NCT06588205Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Fondazione Italiana Linfomi - ETS
Observational
200
Alessandria, Ancona, Bari, Brescia, Candiolo, Castelfranco Veneto, Catania, Civitanova Marche
2025-05-05
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Bari, Meldola, Naples, Orbassano, Rome, Florence, Genova, Padova
2025-04-24
Recruiting
Efficacy of a 2'-Fucosylactose-based Food Supplement on the Prevention of Respiratory and Gastrointestinal Infections.
NCT07050693Gastroenteric Tract, Respiratory Tract, Infections, Gastroenteric Infections
University of Bari
Not applicable
100
Bari
2025-04-17
Recruiting
BeOne Medicines
Phase 3
250
Bari, Florence, Milan, Naples, Novara, Pavia, Perugia, Roma
2025-04-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Aviano, Milan, Pisa, Bari, Brescia, Naples, Padova, Roma
2025-04-09
Recruiting
BRCA Mutation Carriers' Platform a Multicenter Study
NCT07253051BRCA1 Mutation, BRCA2 Mutation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
10,000
Avellino, Aviano, Bari, Bergamo, Catania, Cuneo, Enna, Florence
2025-04-05
Not yet open
University of Campania Luigi Vanvitelli
Phase 2
60
Bari, Naples
2025-04-01
Recruiting
Stanford University
Phase 2
16
Bari
2025-03-28
Recruiting
AbbVie
Observational
700
Milan, Naples, Turin, Rome, Bari, Palermo
2025-03-28
Recruiting
AstraZeneca
Phase 3
400
Bari, Bergamo, Brescia, Cagliari, Catanzaro, Genoa, Milan, Modena
2025-03-28
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 3
340
Aviano, Bari, Brescia, Crema, Cremona, Florence, Genoa, Meldola
2025-03-27
Recruiting
Eli Lilly and Company
Phase 3
700
Bari, Catania, Genova, Meldola, Milan, Monza, Naples, Orbassano
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
582
Bari, Bologna, Catania, Milan, Monza, Naples, Pisa, Ponderano
2025-03-19
Recruiting
Hoffmann-La Roche
Phase 3
600
Bari, Catanzaro, Naples, Rome, Milan, Monza MI, Pavia, Rho
2025-03-17
Recruiting
AstraZeneca
Phase 3
11,300
Alessandria, Bari, Bergamo, Brescia, Chiavari, Cona, Foggia, Milan
2025-03-14
Recruiting
Self-Help Plus for Distress in University Students
NCT06606249Psychological Distress, Psychological Well-Being, Depression, Anxiety
University of Padova
Not applicable
210
Bari, Padova, Verona
2025-03-10
Recruiting
Incyte Corporation
Phase 3
600
Bari, Brescia, Catania, Chieti, Florence, L’Aquila, Milan, Naples
2025-02-28
Active, closed
iOnctura
Phase 2
85
Bari, Naples, Padova, Rozzano, Siena
2025-02-27
Recruiting
Summit Therapeutics
Phase 3
780
Rome, Bari, Bergamo, Milan, Orbassano, Parma, Peschiera del Garda
2025-02-27
Recruiting
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
NCT06588868Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome
Fondazione Italiana Linfomi - ETS
Observational
400
Ancona, Bari, Bologna, Brescia, Cagliari, Catania, Florence, Genova
2025-02-27
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Alessandria, Bari, Bologna, Florence, Genova, Messina, Milan, Modena
2025-02-26
Recruiting
Menarini Group
Phase 2
44
Bari, Bologna, Genoa, Parma, Rome, Torino
2025-02-18
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,000
Acquaviva delle Fonti, Ancona, Avellino, Bari, Bolzano, Brescia, Casale Monferrato, Caserta
2025-02-12
Recruiting
Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants
NCT06823466Ischemic Stroke, Oral Anticoagulation, Atrial Fibrillation (AF), Outcome Assessment
University of L'Aquila
Observational
200
Ancona, Bari, Bologna, Città di Castello, Ferrara, Florence, Frosinone, L’Aquila
2025-02-12
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
60
Bologna, Bari, Cagliari, Catania, Catanzaro, Florence, Genova, Messina
2025-02-12
Recruiting
IRCCS Policlinico S. Donato
Not applicable
200
Bari, San Donato
2025-02-07
Recruiting
LEOPARD Training and Validation Data Collection Study
NCT06675604Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma
Assistance Publique - Hôpitaux de Paris
Observational
4,500
Ancona, Bari, Bologna, Genova, Milan, Modena, Naples, Padova
2025-02-04
Active, closed
University of Bari
Observational
60
Bari
2025-02-02
Not yet open
University of Amsterdam
Not applicable
18
Bari
2025-02-01
Active, closed
Factors of Effectiveness in Italian Forensic Treatment
NCT06854133Forensic Psychiatric Patients, Not Guilty by Reason of Insanity (NGRI), Incompetent to Stand Trial (IST), Psychotic Disorders
University of Bari
Observational
600
Bari
2025-02-01
Recruiting
Azienda Ospedaliera di Perugia
Not applicable
35
Bari, Torino, Milan, Perugia
2025-02-01
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
142
Aviano (PN), Bari, Bologna, Carpi, Cremona, Cuneo, Florence, Lido di Camaiore
2025-01-24
Recruiting
Incyte Corporation
Phase 3
240
Alessandria, Ancona, Bari, Brescia, Catania, Genova, Milan, Naples
2025-01-21
Recruiting
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Not applicable
14
Bari
2025-01-16
Recruiting
University of Bari Aldo Moro
Not applicable
10
Bari
2025-01-10
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Bari, Cona, Florence, Milan, Novara, Padova, Palermo, Perugia
2025-01-03
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
212
Alessandria, Ancona, Ascoli Piceno, Bari, Biella, Bologna, Bolzano, Ferrara
2024-12-13
Active, closed
Hoffmann-La Roche
Phase 2
62
Bari, Rome, Orbassano, Verona
2024-12-09
Recruiting
Anna Estraneo
Not applicable
118
Sant'Angelo dei Lombardi, Bari, Telese Terme, Genova, Milan, Pavia
2024-12-02
Active, closed
ViiV Healthcare
Phase 3
326
Bari, Bergamo, Milan, Roma
2024-12-02
Active, closed
AbbVie
Observational
1,314
Milan, Naples, Turin, Rome, Ancona, Bari, Catanzaro, Pavia
2024-11-26
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Endometrioid Ovarian Cancer
DrugsTORL-1-23·Pegfilgrastim
TORL Biotherapeutics, LLC
Phase 2
230
Bari, Milan, Prato, Rome
2024-11-20
Active, closed
Daiichi Sankyo
Phase 3
700
Bari, Brescia, Meldola, Milan, Novara, Palermo, Roma, Rome
2024-11-19
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
100
Bari, Florence, Genova, Milan, Salerno
2024-11-18
Active, closed
Pfizer
Phase 3
200
L’Aquila, Bari, Milan, Rome, Brescia, Latina, Pavia, Roma
2024-11-15
Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
110
Bari, Milan
2024-11-14
Recruiting
Prismatic Adaptation in Cognitive Rehabilitation
NCT06920784Traumatic Brain Injury
Istituti Clinici Scientifici Maugeri SpA
Not applicable
50
Bari, Pavia, Sciacca, Telese Terme
2024-11-07
Active, closed
Amgen
Phase 2
409
Bari, Bologna, Chieti, Milan
2024-11-07
Recruiting
CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation
NCT06774365Heart Transplantation, Rejection Heart Transplant, HLA Antigens
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
683
Bari, Bologna, Milan, Naples
2024-11-07
Recruiting
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
300
Bari, Bologna, Cagliari, Ferrara, Florence, Foggia, Genova, Messina
2024-11-04
Recruiting
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
600
Alessandria, Bari, Bologna, Brescia, Cagliari, Ferrara, Florence, Foggia
2024-11-04
Recruiting
University College Cork
Observational
300
Feltre, Bari, Milan, Naples, Pavia
2024-11-04
Recruiting
TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial
NCT06685744Parkinson Disease, Multiple Sclerosis, Neurologic Diseases, General
Fondazione Don Carlo Gnocchi ETS
Not applicable
300
Bari, Genova, Lecco, Milan, Modena, Pavia
2024-10-23
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Bari, Ravenna, Monza, Milan, Naples, Rome, Peschiera del Garda, Bergamo
2024-10-07
Recruiting
Efficacy of INM004 in Children With STEC-HUS
NCT06389474Hemolytic-Uremic Syndrome
Inmunova S.A.
Phase 3
220
Bari, Bologna, Genova, Milan, Padova
2024-10-05
Recruiting
AstraZeneca
Phase 3
744
Bari, Milan, Misterbianco, Monza, Naples, Orbassano, Padova, Parma
2024-10-04
Recruiting
Istituto Oncologico Veneto IRCCS
Phase 2
104
Meldola, Messina, Bagno a Ripoli, Aviano, Rozzano, Bari, Bologna, Florence
2024-09-23
Active, closed
Hoffmann-La Roche
Phase 3
338
Bari, Parma, Rome, Genoa, Sassari, Florence, Pisa, Padova
2024-09-23
Recruiting
Heart Care Foundation
Observational
5,000
Montevarchi, Acquaviva delle Fonti, Altamura, Bari, Brescia, Monserrato, Catania, Campobasso
2024-09-15
Recruiting
Consorzio Oncotech
Observational
300
Bari, Bologna, Cuneo, Catania, Meldola, Florence, Genova, Monza
2024-09-13
Active, closed
GCP-Service International West GmbH
Phase 2
41
Ancona, Bari, Candiolo, Florence, Milan, Reggio Calabria
2024-09-10
Recruiting
Prevention ICONA Dedicated Ensemble
NCT07186244PrEP, PrEP Adherence Monitoring, HIV, HIV -1 Infection
Fondazione ICONA
Observational
5,000
Chieti, Pescara, Bari, Foggia, Potenza, Caserta, Naples, Bologna
2024-09-09
By invitation
Giovanni Di Perri
Observational
200
Genova, Milan, Torino, Bari, Catania, Naples, Padova, Roma
2024-09-02
Recruiting
Speech and Language Interventions for Italian People With PPA
NCT06739967Primary Progressive Aphasia(PPA)
Istituti Clinici Scientifici Maugeri SpA
Observational
30
Bari, Milan
2024-09-01
Active, closed
PRIMA Project- Box for Heath and Tradition (B4HT)
NCT06719999Obesity and Obesity-related Medical Conditions
University of Bari
Not applicable
450
Bari
2024-09-01
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Bari, Genova, Modena, Pavia, Rome
2024-08-30
Active, closed
Boehringer Ingelheim
Phase 3
11,000
Alessandria, Asti, Bari, Bergamo, Bologna, Cagliari, Chieri, Chieti
2024-08-30
Recruiting
Fondazione Don Carlo Gnocchi ETS
Not applicable
596
Acerenza, Bari, Bergamo, Catania, Catanzaro, Crotone, Foggia, Genova
2024-08-12
Active, closed
Pfizer
Observational
450
Bari, Rozzano, Bologna, Catania, Roma, Rome
2024-08-07
Active, closed
GlaxoSmithKline
Phase 3
10,212
Negrar, Alessandria, Bari, Belluno, Ferrara, Naples, Palermo, Pessione - Chieri to
2024-08-01
Active, closed
Novartis Pharmaceuticals
Observational
379
Ancona, L’Aquila, Bari, Bergamo, Chieti, Catania, Catanzaro, Cona
2024-07-30
Active, closed
Performance Study with the SiMoT System for in Vitro Diagnostic Tests
NCT06518967Non-interventional Analytical Performance Study on Left-over Samples
Centro di Innovazione Regionale in Single Molecule Digital Assay
Observational
50
Bari
2024-07-16
Recruiting
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Not applicable
80
Bari
2024-07-14
Recruiting
Fondazione Oncotech
Observational
300
Avellino, Ancona, Aviano, Bari, Barletta, Bergamo, Caserta, Genova
2024-07-01
Recruiting
How Complexity and Multiple Illnesses Affect Hospitalized Patients' Health: a Multicenter Study
NCT06872632Complexity and Multiple Illnesses of Adult Hospitalized Internal Medicine Patient
Società Italiana di Medicina Interna
Observational
2,326
Bari, Bologna, Brescia, Ferrara, Florence, Messina, Milan, Modena
2024-06-24
Recruiting
AstraZeneca
Phase 3
240
Ancona, Bari, Catania, Milan, Padova, Palermo, Pavia, Pisa
2024-06-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
550
Bari, Milan, Florence, Roma
2024-06-11
Active, closed
Amgen
Phase 3
563
Bari, Milan, Verona
2024-06-05
Recruiting
Immunocore Ltd
Phase 3
680
Bari, Bergamo, Meldola, Milan, Modena, Naples, Padova, Perugia
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Bari, Monserrato, Rome, Milan, Rozzano, Naples, Turin, Pontedera
2024-06-05
Recruiting
Istituto Auxologico Italiano
Observational
5,000
Acri, Ancona, Bari, Bergamo, Bologna, Cagliari, Catania, Corigliano-Rossano
2024-06-01
Active, closed
Janssen Research & Development, LLC
Phase 2
333
Bari, Ferrara, Florence, Milan, Novara, Padova, Palermo, Perugia
2024-05-30
Recruiting
Daiichi Sankyo
Phase 3
540
Bari, Bergamo, Brescia, Catania, Catanzaro, Genova, Milan, Monza
2024-05-21
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 3
122
Bari, Bologna, Brescia, Catania, Meldola, Milan, Novara, Palermo
2024-05-21
Active, closed
European Myeloma Network B.V.
Phase 2
50
Bari, Bergamo, Florence, Genova, Meldola, Novara, Padova, Pavia
2024-05-14
Recruiting
W.L.Gore & Associates
Observational
2,000
Ancona, Bari, Pavia, Torino, Verona
2024-05-07
Recruiting
University of Bari Aldo Moro
Not applicable
76
Bari
2024-05-06
Active, closed
Azienda Ospedaliero, Universitaria Pisana
Observational
1,000
Bari, Catania, Pisa
2024-05-01
By invitation
Travere Therapeutics, Inc.
Phase 3
100
Bari, Genova, Milan, Monza, Padova
2024-04-30
Recruiting
AstraZeneca
Phase 3
3,850
Acquaviva delle Fonti, Bari, Bergamo, Brescia, Catania, Catanzaro, Cona, Cortona
2024-04-12
Recruiting
International Extranodal Lymphoma Study Group (IELSG)
Observational
300
Alessandria, Bari, Bergamo, Brescia, Catania, Cona, Florence, Messina
2024-04-11
Recruiting
Italian Sarcoma Group
Observational
250
Rozzano, Aviano, Orbassano, Bari, Bologna, Florence, Genova, Milan
2024-03-29
Recruiting
Italfarmaco
Phase 3
220
Bari, Reggio Calabria, Bologna, Meldola, Reggio Emilia, Udine, Rome, Bergamo
2024-03-26
Active, closed
Cochlear
Not applicable
148
Bari, Padova
2024-03-18
Recruiting
Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors
NCT05934084Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS
Not applicable
552
Ancona, Aviano, Bari, Belluno, Barletta, Bolzano, Brescia, Brindisi
2024-02-26
Active, closed
AstraZeneca
Phase 2
142
Bari, Bologna, Milan, Naples, Palermo, Pavia, Peschiera del Garda
2024-02-22
Active, closed
ViiV Healthcare
Phase 3
307
Bari, Bergamo, Padova, Pavia, Sassari
2024-02-21
Recruiting
Amicus Therapeutics
Observational
500
Bari, Naples, Torino, Udine
2024-02-16
Active, closed
Boehringer Ingelheim
Phase 3
428
Bari, Candiolo (TO), Catania, Naples, Parma, Roma, Varese
2024-02-09
Recruiting
Daiichi Sankyo
Phase 3
250
Bari, Bologna, Genova, Milan, Misterbianco, Naples, Padova, Prato
2023-12-30
Recruiting
Travere Therapeutics, Inc.
Phase 3
70
Bari, Genova, Milan, Monza, Padova
2023-12-28
Recruiting
Fondazione Italiana Linfomi - ETS
Observational
1,500
Viagrande, Pescia, Alessandria, Ancona, Avellino, Aviano, Bari, Barletta
2023-12-27
Recruiting
Eli Lilly and Company
Phase 3
1,264
Bari, Bologna, Catania, Milan, Naples, Padova, Roma, Rome
2023-12-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Bari, Meldola, Udine, Milan, Bergamo, Catanzaro, Florence, Roma
2023-12-15
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
190
Sassuolo, Alessandria, Avellino, Aviano, Bari, Biella, Brescia, Cagliari
2023-12-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Bologna, Aviano, Rome, Milan, Rozzano, Candiolo, Bari, Brescia
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Bari, Aviano, Udine, Milan, Naples, Perugia, Catania, Cuneo
2023-12-06
Active, closed
AstraZeneca
Phase 3
1,898
Bari, Genoa, Meldola, Milan, Naples, Padova, Rome, Rozzano
2023-11-21
Recruiting
Amgen
Phase 3
750
Bari, Brescia, Candiolo, Catania, Florence, Meldola (FC), Milan, Monza (MB)
2023-11-16
Active, closed
GlaxoSmithKline
Phase 2
316
Rozzano, Bari, Bologna, Florence, Genova, Milan, Naples, Novara
2023-11-14
Active, closed
AstraZeneca
Phase 3
863
Alessandria, Bari, Bergamo, Milan, Monza, Orbassano, Padova, Parma
2023-11-09
Active, closed
Amgen
Phase 3
633
Crema, Meldola, Taormina, Rozzano, Alessandria, Bari, Bergamo, Florence
2023-11-02
Active, closed
University of Bari
Observational
60
Bari
2023-11-01
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
170
Reggio Emilia, Bari, Meldola, Milan, Roma, Verona
2023-10-27
Active, closed
AstraZeneca
Phase 3
895
Bari, Bergamo, Milan, Padova, Parma, Pavia, Ravenna, Roma
2023-10-24
Recruiting
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
NCT05879757Multiple Myeloma, Secondary Immunodeficiency (SID)
Takeda
Observational
75
Bari, Catania, Padova, Treviso
2023-10-17
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Bari, Ranica, Brescia, Milan, Roma, Torino, Naples
2023-10-02
Recruiting
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
NCT06236464Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Anus
National Cancer Institute, Naples
Observational
170
Bari, Naples, Novara, Pisa
2023-09-25
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Tricase, Genoa, Rozzano, Lombardy, Giugliano in Campania, Bari, Pozzuoli (NA), Lugo
2023-09-22
Recruiting
AstraZeneca
Phase 3
800
Bari, Bologna, Catania, Florence, Lecco, Milan, Monza, Naples
2023-09-22
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
DrugBelimumab
GlaxoSmithKline
Phase 2/3
300
Roma, Ancona, Bari, Cagliari, Catania, Ferrara, Florence, Milan
2023-09-13
By invitation
argenx
Phase 3
240
Bari, Milan, Pisa, Roma, Rozzano, Udine
2023-09-12
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Bari, Bologna, Milan, Monza
2023-09-01
Active, closed
AnaptysBio, Inc.
Phase 2
420
Milan, Pavia, Bari, Novara, Roma
2023-08-31
Active, closed
AstraZeneca
Observational
151
Alessandria, Ancona, Bari, Barletta, Brindisi, Campobasso, Catania, Catanzaro
2023-08-08
Active, closed
Hoffmann-La Roche
Phase 3
459
Bari, Naples, Bologna, Rome, Genoa, Pavia, Turin
2023-08-08
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Bari, Foggia, Naples, Modena, Trieste, Pavia, Ranica
2023-07-06
Recruiting
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Early Phase 1
84
Bari
2023-07-01
Recruiting
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Not applicable
90
Bari
2023-07-01
Active, closed
OncoC4, Inc.
Phase 3
630
Ancona, Bari, Bergamo, Catania, Milan, Monza, Naples, Palermo
2023-06-28
Active, closed
Swedish Orphan Biovitrum
Observational
165
Bari, Bassano del Grappa, Bologna, Cagliari, Florence, Milan, Novara, Reggio Calabria
2023-06-26
Active, closed
Alfasigma S.p.A.
Observational
509
Bari, Milan, Pisa, Negrar, Palermo, Rozzano, Torino
2023-06-12
Active, closed
AbbVie
Observational
1,019
Florence, Rozzano, Milan, Rome, Bari, Bologna, Messina
2023-06-09
Active, closed
ArriVent BioPharma, Inc.
Phase 3
398
Rozzano, Aviano, Roma, Bari, Meldola, Milan
2023-06-01
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Ancona, Bari
2023-05-09
Active, closed
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
NCT05831176Eosinophilic Gastritis (EoG), Eosinophilic Duodenitis (EoD), Eosinophilic Gastrointestinal Disease (EGID), Eosinophilic Gastroenteritis
DrugDupilumab
Regeneron Pharmaceuticals
Phase 2
22
Rozzano, Palermo, Bari, Milan, Pisa, Roma, Rome
2023-05-03
Recruiting
Fondazione Schena
Phase 4
878
Bari
2023-05-01
Recruiting
Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
NCT06383143AL Amyloidosis, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
760
Bari, Catania, Pavia, Torino
2023-05-01
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Bari, Bergamo, Brescia, Cotignola, Florence, Roma, Torino
2023-04-17
Active, closed
Hoffmann-La Roche
Phase 2
204
Bari, Naples, Bologna, Meldola, Rome, Milan, Terni, Padova
2023-04-13
By invitation
Platelet Rich Plasma (PRP) as Terapeutical Option in Erectil Disfunction (DE)
NCT06768177Erectile Dysfunction Due to General Medical Condition, Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction Associated With Type 2 Diabetes Mellitus, Erectile Dysfunctions
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Not applicable
60
Bari
2023-04-01
Recruiting
AstraZeneca
Phase 3
4,300
Bari, Catania, Catanzaro, Florence, Genova, Grosseto, Milan, Modena
2023-03-31
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2
60
Meldola, Monza, Pesaro, Bari, Bologna, Naples, Padova, Ravenna
2023-03-27
Recruiting
Prismatic Lenses and tDCS in Neglect
NCT05842551Stroke, Ischemic
Istituti Clinici Scientifici Maugeri SpA
Not applicable
30
Bari
2023-03-07
Active, closed
Bristol-Myers Squibb
Phase 3
579
Genova, Siena, Bari, Milan, Naples, Perugia, Roma
2023-03-06
Active, closed
Novartis Pharmaceuticals
Observational
242
Alessandria, Ancona, Bari, Bologna, Como, Cosenza, Catania, Florence
2023-03-02
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Chieti, Bari, Modena, Parma, Rome, San Donato Milanese (MI), Latina, Pavia
2023-03-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
65
Bologna, Caserta, Bari, Ferrara, Florence, Milan, Novara, Padova
2023-03-01
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 1/2
122
Alessandria, Candiolo, Avellino, Aviano, Bari, Brescia, Lecce, Meldola
2023-02-27
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
DrugsTovorafenib·Carboplatin
Day One Biopharmaceuticals, Inc.
Phase 3
418
Milan, Roma, Torino, Bari, Florence, Genova, Naples, Padova
2023-02-27
Recruiting
Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment
NCT05870163Gastroesophageal Reflux Disease (GERD)
Implantica CE Reflux Ltd.
Observational
2,500
Bari, Naples
2023-02-20
Active, closed
Genmab
Phase 3
900
Alessandria, Bari, Brescia, Bologna, San Giovanni Rotondo, Milan, Naples, Palermo
2023-02-08
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Not applicable
156
Telese Terme, Lumezzane, Montescano, Tradate, Bari, Pavia
2023-01-26
Active, closed
Cenobamate in Adults With Focal-Onset Seizures
NCT05859854Epilepsy, Focal-Onset Seizure, Neurological Disorder
Aziende Chimiche Riunite Angelini Francesco S.p.A
Observational
936
Bari, Catanzaro, Pozzilli, Pavia, Roma, Torino, Conegliano, Udine
2023-01-24
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Ancona, Naples, Meldola, Milan, Bari, Cuneo, Perugia, Rome
2023-01-16
Active, closed
Exelixis
Phase 3
317
Rozzano, Candiolo, Arezzo, Bari, Brescia, Meldola, Milan, Naples
2023-01-01
Recruiting
University of Bari
Observational
55
Bari
2023-01-01
Recruiting
The Echodynamic Approach
NCT06859047Echocardiography, Transthoracic, Right-heart Hemodynamics
IRCCS Ospedale San Raffaele
Observational
200
Bari, Milan, Pavia
2023-01-01
Recruiting
Meyer Children's Hospital IRCCS
Observational
1,000
Florence, Bari, Belluno, Bologna, Genova, Milan, Modena, Naples
2022-12-22
Recruiting
European Myeloma Network (EMN) Sample Project
NCT06237803Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma
European Myeloma Network B.V.
Observational
6,000
Alessandria, Ancona, Bari, Bologna, Brescia, Civitanova Marche, Florence, Genova
2022-12-21
Recruiting
Iperboreal Pharma Srl
Phase 3
170
Ascoli Piceno, Bagno a Ripoli, Bari, Brescia, Chieti, Genova, L’Aquila, Milan
2022-12-14
Recruiting
Gilead Sciences
Phase 3
1,514
Bari, Bologna, Florence, Genova, Meldola, Milan, Misterbianco, Modena
2022-12-12
Recruiting
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
NCT05524298Low Grade Non-Hodgkin's Lymphoma, Adult
Fondazione Italiana Linfomi - ETS
Observational
150
Alessandria, Ancona, Bari, Brescia, Castelfranco Veneto, Catania, Florence, Messina
2022-12-07
Active, closed
Novartis Pharmaceuticals
Phase 2
95
Bari, Rozzano, Roma, Orbassano
2022-12-06
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Chieti, Bari, Catanzaro, Naples, Udine, Rome, Genoa, Bergamo
2022-11-21
Active, closed
Xeltis Hemodialysis Access Graft: aXess Pivotal Study
NCT05473299End-stage Renal Disease
Xeltis
Not applicable
120
Ancona, Bari, Bologna, Padova, Varese
2022-11-04
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Bari, Catanzaro, San Donato Milanese (MI), Roma, Siena, Bologna, Catania, Padova
2022-11-01
Recruiting
The Italian Registry of Malnutrition in Oncology
NCT06337019Cancer, Cancer Metastatic
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
1,500
Bari, Castellana Grotte, Bologna, Meldola, Genova, Milan, Aviano, Padova
2022-10-25
Recruiting
National Database on Primary Sclerosing Cholangitis (PSC)
NCT05618145Primary Sclerosing Cholangitis
University of Milano Bicocca
Observational
6,000
Ancona, Bari, Bergamo, Bologna, Bolzano, Brescia, Cagliari, Castellana Grotte
2022-10-21
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Ancona, Bari, Bologna, Brescia, Catania, Milan, Padova, Palermo
2022-10-13
Active, closed
Eli Lilly and Company
Phase 3
15,374
Bari, Bologna, Como, Ferrara, Florence, Latina, Padova, Palermo
2022-10-11
Recruiting
Istituto Auxologico Italiano
Observational
3,000
Mascalucia, Bari, Milan, Reggio Emilia, Trieste
2022-10-01
Active, closed
Genmab
Phase 3
549
San Giovanni Rotondo, Milan, Turin, Aviano, Rome, Candiolo, Alessandria, Bari
2022-09-20
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Bari, Catania, Messina, Milan, Monserrato, Monza, Negrar, Palermo
2022-09-19
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Alessandria, Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Cosenza
2022-09-08
Recruiting
University of Milano Bicocca
Observational
500
Bari, Bologna, Brescia, Catania, Naples, Roma, Torino, Udine
2022-09-08
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Not applicable
90
Bari
2022-09-01
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
538
Acquaviva delle Fonti, Bari
2022-08-09
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Bari, Bologna, Milan, Orbassano, Padova, Ravenna, Roma, Rome
2022-08-05
Active, closed
Eli Lilly and Company
Phase 4
780
Bari, Naples, Milan, Moncalieri, Olbia, Palermo, Pisa, Catanzaro
2022-08-01
Active, closed
Gilead Sciences
Phase 3
443
Bari, Bologna, Brescia, Genova GE, Lecco, Lucca, Milan, Monza
2022-07-25
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Bari, Catania, Messina, Milan, Monopoli, Monserrato, Monza, Negrar ( Ve)
2022-07-22
Active, closed
Gilead Sciences
Phase 3
623
Bari, Bologna, Brescia, Genova GE, Lecco, Lucca, Milan, Monza
2022-07-20
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Naples, San Giovanni Rotondo, Genoa, Rozzano, Candiolo, Pisa, Bari, Brescia
2022-07-14
Active, closed
GlaxoSmithKline
Phase 3
163
Bari, Brescia, Florence, Milan, Pavia, Pisa, Roma, Torrette AN
2022-07-14
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
1,000
Legnano, Orbassano, Ancona, Bari, Bergamo, Brescia, Cagliari, Cosenza
2022-07-13
Active, closed
Daiichi Sankyo
Phase 3
586
Bari, Chieti, Lucca, Milan, Orbassano, Parma, Perugia, Roma
2022-07-08
Recruiting
Pfizer
Phase 4
210
Bari, Perugia, Rome, Candiolo, Padova, Bologna, Milan, Naples
2022-07-05
Recruiting
Nuvalent Inc.
Phase 1/2
840
Ancona, Bari, Milan, Padova, Ravenna, Rome
2022-06-09
Recruiting
Pirfenidone to Prevent Fibrosis in Ards.
NCT05075161Acute Respiratory Distress Syndrome (ARDS)
DrugPirfenidone
Università Vita-Salute San Raffaele
Phase 3
130
Milan, Alessandria, Bari, Brescia, Cagliari, Merano, Palermo, Pisa
2022-06-01
Recruiting
Dimerix Bioscience Pty Ltd
Phase 3
286
Bari, Bologna, Genova, Milan, Pavia, Roma, Torino
2022-05-30
Recruiting
MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
NCT05487612Coronary Artery Disease, Aortic Valve Stenosis, Extracorporeal Circulation; Complications
Aristotle University Of Thessaloniki
Not applicable
1,300
Bari, Palermo
2022-05-26
Active, closed
Hoffmann-La Roche
Phase 3
188
Chieti, Bari, Rome, Milan, Catania
2022-05-19
Active, closed
IO Biotech
Phase 3
407
Ancona, Aviano, Bari, Candiolo, Genova, Meldola, Milan, Naples
2022-05-17
Active, closed
Pierre Fabre Medicament
Phase 3
815
Meldola, Taormina, Naples, Aviano, Bari, Bergamo, Cuneo, Genova
2022-05-02
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
50
Bologna, Bari, Milan
2022-04-23
Recruiting
UNICANCER
Phase 3
300
Bari, Candiolo, Foggia, Meldola, Milan, Naples, Roma, Rozzano
2022-04-19
By invitation
AstraZeneca
Phase 3
214
Arezzo, Bari, Catania, Meldola, Milan, Modena, Padova, Pisa
2022-04-19
Active, closed
ARCAGY/ GINECO GROUP
Phase 3
260
Aviano, Bari, Biella, Brescia, Faenza, Lucca, Lugo, Milan
2022-04-15
Recruiting
Zimmer Biomet
Observational
500
Bari, Florence
2022-04-11
Recruiting
AbbVie
Phase 3
768
Misterbianco, Milan, Naples, Rome, Bari, Cremona, Messina, Perugia
2022-03-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Bari, Meldola, Rome, Milan, Orbassano, Florence, Arezzo, Bologna
2022-03-15
Active, closed
Eli Lilly and Company
Phase 3
368
Misterbianco, Meldola, Udine, Bari, Grosseto, Milan, Viterbo
2022-03-11
Active, closed
Daiichi Sankyo
Phase 3
740
Bari, Chieti, Lucca, Milan, Naples, Perugia, Rome, Varese
2022-03-04
Recruiting
Pfizer
Phase 3
640
Bari, Brescia, Latina, Rome, Milan
2022-02-28
Active, closed
AstraZeneca
Phase 3
390
Bari, Catania, Florence, Genova, Milan, Naples, Padova, Parma
2022-02-21
Recruiting
Meyer Children's Hospital IRCCS
Observational
290
Florence, Bari, Brescia, Catanzaro, Lecce, Milan, Padova, Pavia
2022-02-10
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Cona, Milan, Naples, Rome, Negrar, Bari, Chieti, Udine
2022-01-13
Recruiting
Azienda Ospedaliero-Universitaria Careggi
Observational
10,000
Bari, Bologna, Florence, Foggia, Genova, Messina, Milan, Naples
2022-01-10
Recruiting
Nuvalent Inc.
Phase 1/2
359
Ancona, Bari, Milan, Padova, Ravenna, Rome
2022-01-04
Active, closed
Eli Lilly and Company
Phase 3
152
Bari, Milan, Rozzano, Naples, Orbassano, Padova
2021-12-20
Active, closed
Novartis Pharmaceuticals
Phase 3
210
Bari, Bergamo, Bologna, Florence, Genova, Milan, Rozzano, Palermo
2021-12-17
Recruiting
Takeda
Phase 2
135
Bari, Bologna, Brescia, Florence, Genova, Milan, Reggio Emilia, Roma
2021-12-16
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 3
162
Meldola, Alessandria, Bari, Catania, Chieti, Ferrara, Genova, Mestre
2021-12-14
Recruiting
Epidemiological Study on Invasive Bacterial Diseases
NCT06322290Invasive Bacterial Diseases (IBD)
Meyer Children's Hospital IRCCS
Observational
5,000
Adria, Ancona, Andria, Bari, Bologna, Brescia, Campobasso, Camposampiero
2021-12-09
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
101
Alessandria, Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Castelfranco Veneto
2021-12-03
Recruiting
Janssen Pharmaceutica N.V., Belgium
Observational
300
Bari, Bologna, Catania, Civitanova Marche, Genova, Lecce, Meldola, Padova
2021-11-18
Active, closed
AbbVie
Observational
873
Bari, Catania, Genoa, Messina, Milan, Turin, Roma, Cava de' Tirreni
2021-11-17
Active, closed
Amgen
Phase 3
303
Bari, Bergamo, Bologna, Genova, Lecce, Mestre (VE), Milan, Naples
2021-11-02
Active, closed
AstraZeneca
Phase 3
148
Arezzo, Avellino, Bari, Bologna, Florence, Meldola, Milan, Naples
2021-10-28
Recruiting
argenx
Phase 2/3
12
Bari, Florence, Genova
2021-10-26
Recruiting
University of Bari
Not applicable
20
Bari
2021-10-25
Active, closed
Camurus AB
Phase 3
332
Bari, Bologna, Brescia, Florence, Genova, Meldola, Milan, Modena
2021-10-22
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Bari, Bergamo, Bologna, Florence, Meldola, Pavia, Roma, Turin
2021-10-14
Active, closed
Hoffmann-La Roche
Phase 2
176
Bari, Naples, Rome, Milan
2021-10-07
Recruiting
BeOne Medicines
Phase 1/2
246
Ancona, Bari, Bologna, Meldola, Milan
2021-09-16
Active, closed
Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL
NCT04722848Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), ALL, Adult, Philadelphia-Positive ALL
DrugsPonatinib·Imatinib·Blinatumomab
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
236
Ascoli Piceno, Bari, Bergamo, Bolzano, Brescia, Mestre, Modena, Pagani
2021-09-08
Active, closed
Nuvation Bio Inc.
Phase 2
217
Bari, Catania, Milan, Monserrato, Naples, Roma
2021-09-01
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Bari, Campobasso, Catanzaro, Florence, Naples, Palermo, Pisa, Potenza
2021-08-25
Recruiting
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
NCT05003986Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy, IgA Vasculitis
DrugSparsentan
Travere Therapeutics, Inc.
Phase 2
67
Bari, Genova, Milan, Padova, Roma
2021-08-12
Active, closed
HUYABIO International, LLC.
Phase 3
450
Milan, Perugia, Bari, Bologna, Misterbianco, Naples, Palermo, Roma
2021-08-12
Active, closed
AstraZeneca
Phase 3
712
Bari, Florence, Meldola, Milan, Padova, Pozzuoli, Reggio Emilia, Roma
2021-08-05
Recruiting
Observational Study in Localized Osteosarcoma
NCT04890067Localized Osteosarcoma
Italian Sarcoma Group
Observational
120
Aviano, Candiolo, Trieste, Bari, Bologna, Catania, Florence, Genova
2021-07-30
Active, closed
University of Campania Luigi Vanvitelli
Phase 2
219
Ancona, Acquaviva delle Fonti, Bari, Castellana Grotte, Benevento, Brindisi, Monserrato, Catania
2021-07-15
Active, closed
Hoffmann-La Roche
Phase 3
451
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2021-07-14
Active, closed
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
NCT05027984Coronary Artery Disease, Coronary Disease, Ischemic Heart Disease
Centro per la Lotta Contro l'Infarto - Fondazione Onlus
Not applicable
1,425
Ascoli Piceno, Acquaviva delle Fonti, Bari, Bergamo, Benevento, Bologna, Cagliari, Aversa
2021-06-30
Active, closed
Hoffmann-La Roche
Phase 3
142
Bari, Naples, Brescia, Monza, Turin
2021-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Rome, Milan, Monza, Rozzano, Bari, Catania, Naples, Padova
2021-06-18
Recruiting
Observational Study on Skeletal Ewing's Sarcoma
NCT04845893Ewing Sarcoma of Bone
Italian Sarcoma Group
Observational
100
Rozzano, Aviano, Candiolo, Bari, Bologna, Florence, Genova, Milan
2021-06-01
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna, San Giovanni Rotondo, Bari, Cagliari, Novara, Palermo, Reggio Emilia, Terni
2021-05-20
Active, closed
Alectinib in Neo-adjuvant Treatment of Stage III NSCLC
NCT05015010Non Small Cell Lung Cancer
DrugAlectinib
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
33
Meldola, Lido di Camaiore, Monza, Aviano, Orbassano, Bari, Bologna, Catania
2021-05-20
Active, closed
Alfasigma S.p.A.
Observational
1,304
Bari, Brescia, Catania, Ferrara, Genova, Milan, Naples, Roma
2021-05-11
Recruiting
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Not applicable
190
Bari
2021-05-10
Active, closed
Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse
NCT04475731Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse
DrugPonatinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
67
Ancona, Ascoli Piceno, Avellino, Bari, Bergamo, Bologna, Brescia, Cuneo
2021-05-04
Active, closed
Incyte Corporation
Phase 3
654
Bari, Brescia, Candiolo, Catania, Lecce, Milan, Naples, Novara
2021-04-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Modena, Rome, Bari, Milan, Naples, Terni
2021-04-14
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Bari, Bologna, Brescia, Milan, Naples, Pavia, Reggio Emilia, Roma
2021-04-05
Active, closed
Hoffmann-La Roche
Phase 3
751
Chieti, Bari, Naples, Rome, Genoa, Milan, Montichiari, Pavia
2021-03-24
Active, closed
EMN Trial Office S.r.l. Impresa Sociale
Phase 2
50
Bari, Milan, Perugia, Roma, Trieste, Udine
2021-03-21
Recruiting
Fondazione EMN Italy Onlus
Observational
1,900
Florence, Ancona, Bari, Bologna, Brescia, Catania, Genova, Milan
2021-03-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Meldola, Rozzano, Orbassano, Arezzo, Bari, Milan, Pavia, Roma
2021-02-25
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Alessandria, Avellino, Aviano, Bari, Brescia, Candiolo, Catania, Florence
2021-02-23
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
38
Bari, Florence, Genova, Perugia, Roma, Rozzano
2021-02-12
Recruiting
Centro Cardiologico Monzino
Observational
10,000
Milan, Ancona, Bari, Bergamo, Brescia, Foggia, Naples, Palermo
2021-02-10
Active, closed
Pfizer
Phase 3
257
Udine, Milan, San Sisto, Roma, Rome, Siena, Candiolo, Bari
2021-01-15
Active, closed
Genmab
Phase 3
483
Bari, Bergamo, Brescia, Meldola, Milan, Novara, Pavia, Ravenna
2021-01-13
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Bari, Florence, Genova, Milan, Pisa, Roma, Rome, Torino
2020-12-18
Active, closed
AstraZeneca
Phase 3
358
Bari, Florence, Monza, Orbassano, Padova, Rozzano, Varese
2020-12-16
Active, closed
Daiichi Sankyo
Phase 3
1,600
Catania, Milan, Ancona, Aviano, Bari, Belluno, Bologna, Brindisi
2020-12-04
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Aviano, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Meldola
2020-12-02
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
274
Alessandria, Ancona, Ascoli Piceno, Bari, Bologna, Brescia, Brindisi, Castelfranco Veneto
2020-11-27
Active, closed
Associazione Italiana per lo Studio del Pancreas
Phase 3
261
Aviano, Bari, Bergamo, Bologna, Brescia, Florence, Meldola, Milan
2020-11-03
Active, closed
Acerta Pharma BV
Phase 3
611
Bari, Bergamo, Bologna, Florence, Genova, Meldola, Milan, Novara
2020-10-08
Active, closed
European Myeloma Network B.V.
Phase 3
302
Ancona, Bari, Bologna, Brescia, Cuneo, Florence, Novara, Pavia
2020-09-25
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
414
Alessandria, Ancona, Ascoli Piceno, Avellino, Bari, Bologna, Caserta, Castelfranco Veneto
2020-09-24
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
239
Bari, Tricase, Milan, Bologna, Trieste
2020-08-20
Recruiting
Nordic Lymphoma Group
Phase 3
300
Aviano, Bari, Calabria, Monza, Naples, Roma, Segrate, Trieste
2020-08-19
Active, closed
Hoffmann-La Roche
Phase 3
271
Bari, Genoa, Brescia, Florence, Padova
2020-08-10
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome
University of Siena
Observational
3,500
Siena, Bari, Bolzano, Brescia, Cagliari, Catania, Catanzaro, Chieti
2020-08-06
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
321
Cona, Alessandria, Bari, Cagliari, Catania, Catanzaro, Cosenza, Florence
2020-07-24
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
572
Alessandria, Asti, Bari, Bologna, Cagliari, Florence, Milan, Modena
2020-05-29
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Bari, Rome, Milan, Florence, Modena, Naples, Province of Macerata
2020-05-19
Recruiting
Federico II University
Observational
5,000
Arzignano, Bari, Caserta, Catanzaro, Eboli, Foggia, Genova, Lecce
2020-03-07
Recruiting
Lactobacillus Reuteri Strain Combination in Children Treated With PPI
NCT05484128Gastric Lesion, Proton Pump Inhibitor Adverse Reaction, Probiotic
University of Bari
Not applicable
172
Bari
2020-03-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
Rome, Padova, Bari, Catania, Roma
2020-02-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Verona, Arezzo, Bari, Bologna, Milan, Modena, Padova, Pavia
2020-02-27
Active, closed
Pfizer
Phase 3
1,068
Misterobianco (CT), Cremona, Rozzano, Turin, Reggio Emilia, Arezzo, Bari, Genova
2019-12-30
Recruiting
Terumo Aortic Global Endovascular Registry
NCT04246463Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Surgery
Vascutek Ltd.
Observational
1,000
Bari, Bolzano, Cagliari, Careggi, Catania, Modena, Siena, Turin
2019-12-17
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
100
Brescia, San Giovanni Rotondo, Tricase, Monza, Ancona, Ascoli Piceno, Bari, Bologna
2019-12-09
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
120
Cagliari, Naples, Ancona, Bari, Bologna, Brescia, Cuneo, Florence
2019-12-06
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab Beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Bari, Brescia, Catania, Florence, Genova, Modena, Parma, Pavia
2019-11-05
Active, closed
Consorzio Oncotech
Observational
600
Aviano, Bari, Bergamo, Brindisi, Chieti, Como, Cuneo, Florence
2019-10-24
Recruiting
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 2
89
San Giovanni Rotondo, Bari, Bergamo, Bologna, Cagliari, Catania, Florence, Genova
2019-10-09
Active, closed
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
NCT04050436Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
DrugsVusolimogene Oderparepvec·Cemiplimab
Replimune, Inc.
Phase 2
231
Bari
2019-10-08
Recruiting
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
NCT03955445C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis
DrugIptacopan
Novartis Pharmaceuticals
Phase 3
225
Bari, Ranica, Roma
2019-10-03
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Bari, Carbonara di Bari, Catanzaro, Avellino
2019-10-03
Active, closed
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas
NCT03697512Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma
DrugsIbrutinib·Rituximab
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
175
Ponderano, Milan, Torino, Ancona, Bari, Brescia, Cagliari, Pavia
2019-09-27
Recruiting
National Database on Primary Biliary Cholangitis
NCT05151809Primary Biliary Cholangitis
University of Milano Bicocca
Observational
6,000
Ancona, Bari, Bergamo, Bologna, Bolzano, Brescia, Cagliari, Castellana Grotte
2019-09-19
Not yet open
Hepatocarcinoma Recurrence on the Liver Study - Part2
NCT04053231Liver Cancer, Surgery, Recurrence Tumor, Cirrhosis
University of Milano Bicocca
Observational
3,000
Bari, Bologna, Bolzano, Brescia, Forlì, Lecco, Mantua, Milan
2019-09
Recruiting
University Hospital Muenster
Phase 3
683
Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Cona
2019-08-23
Active, closed
Sanofi
Observational
1,860
Terracina, Naples, Padua, Bari, Bologna, Brescia, Catania, Milan
2019-08-15
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Meldola, Rozzano, Roma, Bari, Bergamo, Candiolo, Catania, Genova
2019-08-09
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
75
Castelfranco Veneto, Alessandria, Ancona, Avellino, Aviano, Bari, Brescia, Cagliari
2019-07-02
Active, closed
Fondazione EMN Italy Onlus
Phase 2
45
Ancona, Bari, Bergamo, Bologna, Brescia, Catania, Milan, Novara
2019-07-01
Active, closed
Fondazione EMN Italy Onlus
Phase 3
84
Alessandria, Ancona, Ascoli Piceno, Bari, Bergamo, Bolzano, Brescia, Cagliari
2019-07-01
Active, closed
Biomarkers of Cancer-Associated Myositis
NCT06808672Dermatomyositis
Azienda USL Reggio Emilia - IRCCS
Observational
50
Bari, Reggio Emilia
2019-06-13
Active, closed
Sanofi
Observational
955
Torrette Di Ancona, Terracina, Rome, Bari, Brescia, Cagliari, Genova, L’Aquila
2019-06-11
Recruiting
Protocol ITANET - Registry
NCT04282083Gastro-entero Pancreatic Neuroendocrine Tumors
Italian Association Neuroendocrine Tumors
Observational
3,600
Rozzano, Peschiera del Garda, Ancona, Bari, Bologna, Bolzano, Brescia, Brindisi
2019-05-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Chieti, Milan, Turin, Bolzano, Florence, Arezzo, Bari, Genova
2018-12-24
Active, closed
Travere Therapeutics, Inc.
Phase 3
406
Ranica, Milan, Bari, Catania, Catanzaro, Lecco, Modena, Pavia
2018-12-11
Active, closed
AstraZeneca
Phase 3
825
Ancona, Bari, Bergamo, Florence, Milan, Monza, Padova, Roma
2018-12-06
Active, closed
AstraZeneca
Phase 3
1,063
Bari, Bologna, Florence, Milan, Naples, Orbassano, Pozzuoli, Verona
2018-11-16
Active, closed
National Register of Actionable Mutations
NCT05918666Solid Tumours in Advanced Stages
Federation of Italian Cooperative Oncology Groups
Observational
2,098
Ancona, Arezzo, Avellino, Aviano, Bari, Bergamo, Brindisi, Catania
2018-10-27
Recruiting
Associazione Angela Serra per la ricerca sul cancro
Observational
1,000
Bari, Palermo, Terni
2018-10-14
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2018-09-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Meldola, Bari, Bergamo, Genova, Milan, Naples, Padova, Roma
2018-09-12
Recruiting
University of Leeds
Observational
500
Bari
2018-09-01
Recruiting
Martin Schrappe
Phase 3
5,000
Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Catanzaro
2018-07-15
Active, closed
Hoffmann-La Roche
Phase 3
927
Bari, Naples, Trieste, Rome, Genoa, Milan, Pavia, Pozzilli
2018-05-28
Recruiting
Octapharma
Observational
200
Bari, Bologna, Castelfranco Veneto, Catania, Florence, Milan, Padova, Rome
2018-02-13
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006Coronary Artery Disease, Heart Diseases
Weill Medical College of Cornell University
Not applicable
4,300
Bari, Brescia, Cotignola, Roma, Rome, Torino
2018-01-07
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Bari, Benevento, Bologna, Brindisi, Cagliari, Florence, Genova, Latina
2017-09-12
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Bari, Bologna, Pavia, Roma, Siena
2017-08-23
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Bari, Bologna, Brescia, Florence, Forlì, Milan, Monza, Naples
2017-06-26
Recruiting
Fosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis, Central Nervous System Bacterial Infections
Infectopharm Arzneimittel GmbH
Observational
1,000
Bari, Cuneo, Genova, Milan, Palermo, Rome, Torino, Udine
2016-12
Active, closed
AstraZeneca
Phase 3
682
Bari, Bergamo, Bologna, Cremona, Florence, Lucca, Meldola, Milan
2015-10-21
Active, closed
Medtronic
Observational
3,100
Bari, Bologna, Brescia, Cotignola, Milan, Pisa, Roma
2015-07
Active, closed
Eli Lilly and Company
Phase 3
545
Bari, Aviano, Orbassano, Bologna, Milan, Padova
2015-05-06
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Ancona, Bari, Bologna, Brescia, San Giovanni Rotondo, Florence, Milan, Rozzano
2015-03-05
Active, closed
Hoffmann-La Roche
Phase 3
154
Bari, Bologna, Meldola, Reggio Emilia, Milan, Monza, Pisa
2015-02-02
Recruiting
CAMpania PugliA bRanch Iliaco
NCT06946381Aortoiliac Aneurysm, Iliac Aneurysm
Federico II University
Observational
200
Bari, Naples
2015-01-01
Active, closed
AstraZeneca
Phase 3
510
Bari, Genova, Livorno, Milan, Naples, Orbassano, Parma, Perugia
2013-09-25
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Bari, Catania, Milan, Naples, Padova, Roma
2013-08-26
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Bari, Montichiari, Catania, Milan, Cefalù, Roma, Gallarate
2013-07-26
Active, closed
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Phase 3
1,000
Casale Monferrato, Fabriano, Avellino, Bari, Bergamo, Treviglio, Benevento, Brindisi
2013-06
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Bari, Naples, Udine, Genoa, Bergamo, Milan, Turin, Florence
2013-05-30
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Bari, Florence, Genova, Milan, Roma, Torino
2013-03-18
Active, closed
Italfarmaco
Phase 2
90
Bari, Bergamo, Florence, Milan, Pescara, Pavia, Reggio Calabria, Vicenza
2013-03
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Not applicable
540
Alessandria, Ancona, Aviano, Bari, Barletta, Bergamo, Bologna, Bolzano
2012-10
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Milan, Bari, Bologna, Genoa, Naples, Rome
2012-07
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Acquaviva delle Fonti, Ancona, Bari, Bologna, Brescia, Caserta, Castrovillari, Cotignola
2012-01
Active, closed
Associazione Qol-one
Phase 2
174
Alessandria, Ancona, Asti, Avellino, Bari, Brindisi, Cagliari, Cosenza
2011-06-11
Active, closed
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up
NCT01357772Carcinoma, Intraductal, Noninfiltrating, Recurrence, Local Neoplasm, Breast Neoplasms, Atypical Hyperplasia
DrugTamoxifen
Andrea DeCensi
Phase 3
500
Tortona, Meldola, Carpi, Bari, Catanzaro, Genoa, Milan, Modena
2008-11-12
Recruiting
Medtronic
Observational
20,000
Ancona, Bari, Bologna, Brescia, Castrovillari, Cotignola, Lecce, Milan
1983-01
Rows per page Showing 1–442 of 442
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 October 2026. https://priyalifescience.com/clinical-trials-italy/city/bari

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 442 of those studies with a site in Bari.

How many clinical trials are recruiting in Bari?

236 of the 442 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 28 have not yet opened recruitment, 171 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bari), 442 studies
PhaseStudiesRecruitingShare
Phase 31837741.4%
Observational1348730.3%
Not applicable574012.9%
Phase 2501811.3%
Phase 4741.6%
Phase 2/3661.4%
Phase 1/2430.9%
Early Phase 1110.2%

Most active sponsors

Lead sponsors with the most studies (Bari)
Lead sponsorStudiesRecruiting
AstraZeneca3115
Merck Sharp & Dohme LLC175
Hoffmann-La Roche163
University of Bari147
Fondazione Italiana Linfomi - ETS136
Novartis Pharmaceuticals113
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari108
Janssen Research & Development, LLC103
Boehringer Ingelheim96
Daiichi Sankyo84
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.